UnitedHealthcare makes Medtronic’s devices the preferred option for type 1 diabetics

UnitedHealthcare’s decision to make devices from Medtronic the preferred insulin pump for type 1 diabetics has angered some patients, the Star Tribune reports. UnitedHealthcare told the newspaper that Medtronic’s devices help prevent complications, making them safer than alternatives.

Ana Gupte, an analyst with Leerink Partners, said collaborations between UnitedHealthcare and Medtronic may continue if this deal results in lower costs and improved outcomes.